CANTON, Mass.--(BUSINESS WIRE)--Conformation-X Therapeutics, LLC, an immune-oncology focused drug development company, announced today that it has closed an oversubscribed funding tranche of $3.65M, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback